Paris, the global hub for art, fashion, gastronomy, and culture is now extensively recognized for its astonishing progress in the Biotechnology industry. A new era of innovation and entrepreneurship is Growing in Ile-de-France, leading to a significant number of biotech startups establishing roots in Paris. Let’s take a look at the promising biotech startups that are making a mark in the industry.
The city has become a global hotspot for biotech innovation, leveraging its rich talent base in scientific research and life sciences to effect a digital revolution in the medical field. The startups listed here are infiltrating various areas of the vast biotech scene – from genomics, gene and cell therapy, precision oncology, to autoimmune therapies with a mission to enhance the quality of human life.
In this article, we highlight 15 Paris domains startups that are making significant strides in the biotech industry, transforming it with their innovative work, and revealing the potential of this vibrant city in leading the world in biotechnology. Their detailed information, including their names, websites, descriptions, industry of operation, and founder’s names follow:
Mnemo Therapeutics
Founded by Alain Maiore, Mnemo Therapeutics concentrates on the biotechnology and life science industry. They specialize in developing AcT-cell based immunotherapies to treat cancer patients.
WhiteLab Genomics
Working in the sector of Biotechnology and Genetics, WhiteLab Genomics focuses on developing digital tools to aid gene and cell therapy companies to develop drugs quicker and at a lower cost.
DeepLife
Founded by Jean-Baptiste Morlot and Jonathan Baptista, DeepLife uses artificial intelligence to model cells and efficiently engineer their behavior. They aim at transforming multi-omics data into assets.
EG 427
Pioneering a new approach in gene therapy called pinpoint gene therapy, EG 427 was founded by Alberto Epstein and Philippe Chambon. The company focuses on cancer and other inherited metabolic diseases.
Ermium Therapeutics
Started by Jean-Philippe Herbeuval, Ermium Therapeutics operates in the biotech industry with a specialization in developing creative therapies for auto-immune diseases.
Epigene Labs
Epigene Labs was launched by Akpeli Nordor and Arthur de Garidel. The startup designs genomics-driven drugs for precision oncology.
Home Biosciences
An innovative European venture builder dedicated to biotech, Home Biosciences was started by David Schilansky and Magali Richard. The startup concentrates on launching startups to develop new biotherapies.
SideROS
SideROS a pioneering biotech firm was founded by Raphaël Rodriguez. They focus on Iron modulation for targeted therapy in oncology.
Plantik Biosciences
Plantik Biosciences, founded by Aditya Nayak and Ying Shao, has aimed to create new plant breeding technology for faster growth. Their goal is to accelerate plant breeding and discover valuable traits.
Corlieve Therapeutics
Corlieve Therapeutics, being led by Richard Porter, is a biotech company that concentrates on CNS and epilepsy. Corlieve works on transformational therapeutic solutions for patients affected by severe neurological disorders.
Gradient Denervation Technologies
Gradient Denervation Technologies is engaged in developing a medical device for the transvascular treatment of pulmonary hypertension. It represents a novel paradigm for the early treatment of pulmonary arterial hypertension.
Regen Lab France
Regen Lab France specializes in the field of biotechnology and pharmaceuticals. They are focused on the development and manufacturing of products for autologous regenerative medicine.
Diagante
Diagante is engaged in developing preanalytical in vitro diagnostic medical devices that preserve and process solid samples. They are working to improve patient care by boosting robustness, reducing costs and simplifying operations in medical labs.
Insiliance
Insiliance employs artificial intelligence for CNS drug repositioning and treatment optimization. Their approach leverages recent scientific advances in AI to identify optimal drug-treatment for neurodegenerative diseases.
Yokai
Yokai, co-founded by Matthieu Bizien and Olivier Zetlers, utilizes technologies like Artificial Intelligence, Big Data, Biotechnology, Education, Machine Learning, Software to virtualize human-centric photography. Yokai is transforming physiological measurement to better understand, predict and ultimately improve health.
To wrap it all up, these Parisian startups are indeed shaping the biotech industry’s future. With their groundbreaking work and innovative technologies, they are bound to take the biotech industry to new heights, bringing Paris at the forefront of scientific achievement.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
